Bariatric Surgery Shows Promise In Preventing Type 2 Diabetes
This article was originally published in The Gray Sheet
At 15 years of follow-up in the Swedish Obese Subjects study, 110 bariatric surgery patients had developed type 2 diabetes versus 392 non-surgery patients in the control group, corresponding to incidence rates of 6.8 cases and 28.4 cases per 1,000 person-years, respectively.
You may also be interested in...
Renowned academic medical center unveils its annual ‘top 10’ list of medical innovations it anticipates will have a major impact on patient care within the next year, including eight that are device-related.
The findings come from two studies, including the randomized STAMPEDE trial, funded by Johnson & Johnson and the National Institutes of Health, comparing medical therapy with two forms of surgical treatment – gastric bypass or sleeve gastrectomy.
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.